New Infectious Disease MDx Firm Mobidiag Formed from Merger | GenomeWeb

NEW YORK (GenomeWeb News) – Finnish firms Mobidiag and Amplidiag and French company Genewave today announced their merger, forming a new entity focused on developing molecular diagnostics targeting infectious diseases.

The new company, which is retaining the Mobidiag name, combines Mobidiag and Amplidiag's high multiplex diagnostic test portfolios and Genewave's automated and integrated test platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.